14030 Ten-year interim results from the ESPRIT registry: Real-world safety, effectiveness, and patient-reported outcomes of adalimumab for moderate to severe psoriasis

• DOI: 10.1016/j.jaad.2020.06.155
• Publication Date: 2020-11-28T02:06:22Z
• Authors: Jashin J. Wu; William Abramovits; Wendell C. Valdec...; Ofelia Reyes Servin; Mareike Bereswill; Dilek Arikan; Dianlin Guo; Hartmut Kupper; Rakesh Singh; Alan Menter
• Keywords: Interim; Interim analysis; Patient registry